COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,588 Articles (22,415 medRxiv, 8,173 bioRxiv)

Most recent first Previous |  Page 1749: Articles 17481-17490  | Next

Genomic surveillance of SARS-CoV-2 in the Bronx enables clinical and epidemiological inference
Fels, J. M., Khan, S., Forster, R., Skalina, K. A., Sirichand, S., Fox, A. S., Bergman, A., Mitchell, W. B., Wolgast, L. R., Szymczak, W. A., Bortz, R. H., Dieterle, M. E., Florez, C., Haslwanter, D., Jangra, R. K., Laudermilch, E., Wirchnianski, A. S., Barnhill, J., Goldman, D. L., Khine, H., Goldstein, D. Y., Daily, J. P., Chandran, K., Kelly, L.
10.1101/2021.02.08.21250641 — Posted: 2021-02-10
Expression of ACE2 receptor, soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin (1-7), is modulated in COVID-19 patients.
OSMAN, I. O., Menelotte, C., Brouqui, P., MILLION, M., LAGIER, J.-c., PAROLA, P., STEIN, A., LA SCOLA, B., MEDDEB, L., MEGE, J.-L., RAOULT, D., DEVAUX, C. A.
10.1101/2021.02.08.21251001 — Posted: 2021-02-10
Novel SARS-CoV-2 spike variant identified through viral genome sequencing of the pediatric Washington D.C. COVID-19 outbreak
LoTempio, J. E., Billings, E. A., Draper, K., Ralph, C., Moshgriz, M., Duong, N., Dien Bard, J., Gai, X., Wessel, D., DeBiasi, R. L., Campos, J. M., Vilain, E., Delaney, M., Michael, D. G.
10.1101/2021.02.08.21251344 — Posted: 2021-02-10 Discussion: Onsite
A Human 3D neural assembloid model for SARS-CoV-2 infection
Gleeson, J. G., Wang, L., Sievert, D., Clark, A. E., Federman, H., Gastfriend, B. D., Shusta, E., Palecek, S., Carlin, A., Clark, A. E.
10.1101/2021.02.09.430349 — Posted: 2021-02-09
Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model
Bessiere, P., Wasniewsk, M., Picard-Meyer, E., Servat, A., Figueroa, T., Foret-Lucas, C., Coggon, A., Lesellier, S., Boue, F., Cebron, N., Gausseres, B., Trumel, C., Foucras, G., Salguero, F. J., Monchatre-Leroy, E., Volmer, R.
10.1101/2021.02.09.430458 — Posted: 2021-02-09
Disruption of nuclear architecture as a cause of COVID-19 induced anosmia
Zazhytska, M., Kodra, A., Hoagland, D. A., Fullard, J., Shayya, H. J., Omer, A., Firestein, S., Gong, Q., Canoll, P., Goldman, J. E., Roussos, P., tenOever, B. R., Overdevest, J. B., Lomvardas, S.
10.1101/2021.02.09.430314 — Posted: 2021-02-09
Exosomes from COVID-19 patients carry tenascin-C and fibrinogen-β in triggering inflammatory signals in distant organ cells
Sur, S., Khatun, M. B., Steele, R., Isbell, S., Ray, R., Ray, R. B.
10.1101/2021.02.08.430369 — Posted: 2021-02-09
Dual RNA-Seq analysis of SARS-CoV-2 correlates specific human transcriptional response pathways directly to viral expression
Maulding, N. D., Seiler, S., Pearson, A., Kreusser, N., Stuart, J.
10.1101/2021.02.09.430517 — Posted: 2021-02-09
A novel antibody against the furin cleavage site of SARS-CoV-2 spike protein: effects on proteolytic cleavage and ACE2 binding
Spelios, M. G., Capanelli, J. M., Li, A. W.
10.1101/2021.02.09.430451 — Posted: 2021-02-09
SARS-CoV-2 RBD-Tetanus toxoid conjugate vaccine induces a strong neutralizing immunity in preclinical studies
Valdes-Balbin, Y., Santana-Mederos, D., Quintero, L., Fernandez, S., Rodriguez, L., Sanchez-Ramirez, B., Perez, R., Acosta, C., Mendez, Y., Ricardo, M. G., Hernandez, T., Bergado, G., Pi, F., Valdes, A., Ramirez, U., Oliva, R., Soubal, J.-P., Garrido, R., Cardoso, F., Landys, M., Farinas, M., Gonzalez, H., Enriquez, J., Noa, E., Suarez, A., Fang, C., Espinosa, L. A., Ramos, Y., Gonzalez, L. J., Climent, Y., Rojas, G., Relova-Hernandez, E., Cabrera, Y., Losada, S. L., Boggiano, T., Ojito, E., Leon-Monzon, K., Chiodo, F., Paquet, F., Chen, G., Rivera, D. G., Garcia-Rivera, D., Verez-Bencomo, V.
10.1101/2021.02.08.430146 — Posted: 2021-02-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).